Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Intangibles (2022 - 2025)

Historic Intangibles for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $258674.0.

  • 60 Degrees Pharmaceuticals' Intangibles fell 2163.93% to $258674.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $258674.0, marking a year-over-year decrease of 2163.93%. This contributed to the annual value of $232225.0 for FY2024, which is 1231.6% down from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Intangibles stood at $258674.0 for Q3 2025, which was down 2163.93% from $239390.0 recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Intangibles' 5-year high stood at $330107.0 during Q3 2024, with a 5-year trough of $164255.0 in Q4 2022.
  • Moreover, its 4-year median value for Intangibles was $239390.0 (2025), whereas its average is $248116.3.
  • Its Intangibles has fluctuated over the past 5 years, first surged by 6123.89% in 2023, then crashed by 2163.93% in 2025.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Intangibles (Quarter) stood at $164255.0 in 2022, then skyrocketed by 61.24% to $264843.0 in 2023, then decreased by 12.32% to $232225.0 in 2024, then rose by 11.39% to $258674.0 in 2025.
  • Its Intangibles stands at $258674.0 for Q3 2025, versus $239390.0 for Q2 2025 and $235029.0 for Q1 2025.